Penumbra (PEN) EBIT Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225.00 |
| Dec 31, 2025 | 1,642.00 |
| Sep 30, 2025 | 2,711.00 |
| Jun 30, 2025 | 2,882.00 |
| Mar 31, 2025 | 1,200.00 |
| Dec 31, 2024 | 627.00 |
| Sep 30, 2024 | 245.00 |
| Jun 30, 2024 | -3,658.00 |
| Mar 31, 2024 | -434.00 |
| Dec 31, 2023 | 678.00 |
| Sep 30, 2023 | 2,331.00 |
| Jun 30, 2023 | -163.00 |
| Mar 31, 2023 | -62.00 |
| Dec 31, 2022 | -183.00 |
| Sep 30, 2022 | 173.00 |
| Jun 30, 2022 | 158.00 |
| Mar 31, 2022 | 81.00 |
| Dec 31, 2021 | -1,806.00 |
| Sep 30, 2021 | 665.00 |
| Jun 30, 2021 | 663.00 |
| Mar 31, 2021 | 479.00 |
| Dec 31, 2020 | -439.00 |
| Sep 30, 2020 | -1,767.00 |
| Jun 30, 2020 | -778.00 |
| Mar 31, 2020 | -980.00 |
| Dec 31, 2019 | 637.00 |
| Sep 30, 2019 | 834.00 |
| Jun 30, 2019 | -5,622.00 |
| Mar 31, 2019 | -5,803.00 |